NTG Nordic Transport Group A/S
Company announcement no. 9 - 21
23 February 2021
Transactions in connection with share buyback program
On 18 November 2020 NTG Nordic Transport Group ("NTG") announced a share buyback program, as described in Company announcement 43 - 20. The program will be executed in accordance with the principles of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (Market Abuse Regulation) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbor rules.
The purpose of the program is to meet obligations relating to acquisition of minority shareholders’ shares in NTG subsidiaries under the "Ring-the-Bell" concept, cover obligations arising under share-based incentive programs, and potentially for other purposes such as payment in relation to potential M&A transactions.
Under the program NTG will purchase up to 165,000 of its own shares (nominally DKK 3,300,000), corresponding to 0.73% of the current share capital of NTG, for an aggregate maximum amount of DKK 30,000,000. The share buyback program will run from 19 November 2020 to 31 March 2021 at the latest, both days inclusive.
The following transactions have been made under the program:
Number of shares | Average purchase price (DKK) | Transaction value (DKK) | |
Accumulated, latest announcement | 98,039 | 22,551,918 | |
16 February 2021 | 2,481 | 243.9 | 605,050 |
17 February 2021 | 2,495 | 244.8 | 610,708 |
18 February 2021 | 2,500 | 253.9 | 634,768 |
19 February 2021 | 2,500 | 250.5 | 626,160 |
22 February 2021 | 2,545 | 243.4 | 619,348 |
Accumulated under the program | 110,560 | 25,647,953 |
With the transactions stated above, NTG owns a total of 290,325 treasury shares, corresponding to 1.28% of the company’s share capital.
Details of each transaction are included as appendix.
Additional information
For additional information, please contact:
Investor relations:
Christian D. Jakobsen, Group CFO +45 76 32 09 89
ir@ntg.dk
Press:
Mathias Jensen-Vinstrup, Group Director +45 76 32 09 90
press@ntg.dk
Attachments
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
Zealand Pharma17.10.2025 17:05:17 CEST | Press release
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom